Superstring Capital Management as of Dec. 31, 2023
Portfolio Holdings for Superstring Capital Management
Superstring Capital Management holds 30 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ImmunoGen | 12.7 | $18M | 598k | 29.65 | |
| Cytokinetics Com New (CYTK) | 10.6 | $15M | 178k | 83.49 | |
| 89bio (ETNB) | 8.1 | $11M | 1.0M | 11.17 | |
| Ionis Pharmaceuticals (IONS) | 6.8 | $9.6M | 190k | 50.59 | |
| Ideaya Biosciences (IDYA) | 6.4 | $8.9M | 251k | 35.58 | |
| Protagonist Therapeutics (PTGX) | 6.2 | $8.7M | 379k | 22.93 | |
| Immunovant (IMVT) | 6.1 | $8.6M | 204k | 42.13 | |
| Bridgebio Pharma (BBIO) | 5.9 | $8.3M | 206k | 40.37 | |
| Day One Biopharmaceuticals I (DAWN) | 4.0 | $5.5M | 380k | 14.60 | |
| Marinus Pharmaceuticals Com New (MRNS) | 3.6 | $5.0M | 462k | 10.87 | |
| Neurocrine Biosciences (NBIX) | 2.8 | $3.9M | 29k | 131.76 | |
| Urogen Pharma (URGN) | 2.7 | $3.8M | 255k | 15.00 | |
| Savara (SVRA) | 2.7 | $3.8M | 814k | 4.70 | |
| Roivant Sciences SHS (ROIV) | 2.6 | $3.7M | 326k | 11.23 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 2.4 | $3.4M | 55k | 62.00 | |
| Fate Therapeutics (FATE) | 2.3 | $3.2M | 848k | 3.74 | |
| Keros Therapeutics (KROS) | 2.1 | $3.0M | 75k | 39.76 | |
| Acelyrin (SLRN) | 1.9 | $2.7M | 357k | 7.46 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.8 | $2.5M | 124k | 19.88 | |
| Nkarta (NKTX) | 1.6 | $2.3M | 347k | 6.60 | |
| Krystal Biotech (KRYS) | 1.4 | $2.0M | 16k | 124.06 | |
| Quanterix Ord (QTRX) | 1.4 | $2.0M | 72k | 27.34 | |
| Axsome Therapeutics (AXSM) | 0.9 | $1.3M | 16k | 79.59 | |
| So Young International Sponsored Ads (SY) | 0.7 | $1.0M | 796k | 1.26 | |
| Immatics SHS (IMTX) | 0.6 | $834k | 79k | 10.53 | |
| Allogene Therapeutics (ALLO) | 0.5 | $713k | 222k | 3.21 | |
| Inozyme Pharma (INZY) | 0.4 | $528k | 124k | 4.26 | |
| Fusion Pharmaceuticals (FUSN) | 0.3 | $440k | 46k | 9.61 | |
| Spruce Biosciences (SPRB) | 0.2 | $348k | 119k | 2.93 | |
| Ys Biopharma Ordinary Shares (YS) | 0.1 | $166k | 308k | 0.54 |
